Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trialRupert Bartsch, Matthias Preusser, Anna S. Berghoff et al.|Nature Medicine|2022Cited by 395
Defining the Role of Stereotactic Radiosurgery Versus Microsurgery in the Treatment of Single Brain MetastasesA. Schöggl, K. Ungersböck, K. Kitz et al.|Acta Neurochirurgica|2000Cited by 195
Activity of T-DM1 in Her2-positive breast cancer brain metastasesRupert Bartsch, Matthias Preusser, Anna S. Berghoff et al.|Clinical & Experimental Metastasis|2015Cited by 122
Brain metastases free survival differs between breast cancer subtypesAnna S. Berghoff, Rupert Bartsch, Florian Fitzal et al.|British Journal of Cancer|2012Cited by 94
Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastasesRupert Bartsch, G. Steger, Anna S. Berghoff et al.|British Journal of Cancer|2011Cited by 77